발행물
컨퍼런스
ISPOR EUROPE 2022
,
Real-World Effectiveness of CDK 4/6 Inhibitor As First-Line Treatment in Patients With HR+, HER2- Advanced Breast Cancer in South Korea - Focused on Underrepresented Younger and Older Age
ISPOR Europe 2022
Real-World Effectiveness of Palbociclib With Concomitant Proton Pump Inhibitor in Patients With Breast Cancer in South Korea: A Retrospective Cohort Study
Cost-Effectiveness of Adherence Intervention for Tuberculosis Treatments in South Korea Using Discrete Event Simulation Model
Cost-Effectiveness of Everolimus Combination Therapy in Patients After Liver Transplantation Focusing on Cancer Risk: A Markov Model Using Real-World Data
Healthcare Resource Utilization and Costs Associated With Previously Treated Advanced Non-Small Cell Lung Cancer Patients Without EGFR Mutations or ALK Rearrangements in Korea